KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Subject heading: KITE & Gilead UK/I 2023 CAR-T Fellowship and Medical Grants Programme now open

Do you have a project that could improve patient care in the field of CAR T-cell therapy and haemato-oncology?

The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme (GFP) is a medical grants funding stream that helps drive innovation and supports best practice sharing initiatives amongst healthcare professionals. Its aim is to help improve patient care within the field of CAR T-cell therapy and haemato-oncology. The GFP has funded nearly 350 projects since 2008.

The 2023 CAR-T GFP is accepting applications until June 30th.

The GFP accepts applications for projects that will add clinical value or address an unmet need in the care of patients within the field of CAR T-cell therapy and haemato-oncology. If you have a project that falls outside of this scope, but which will add clinical value or which investigates an area of unmet need within CAR T-cell therapy and haemato-oncology, you may still apply.

If you are interested in learning about the GFP or the application process, or to check if your project is eligible for a grant and apply, please visit the Gilead UK and Ireland website here. For general enquiries or questions about an application, please email [email protected] for support.

Disclaimer: The Kite and Gilead UK & Ireland Fellowship and Medical Grants Programme is fully operated and funded by Kite, a Gilead Company.

 

 

Date of preparation: April 2023

Code: UK-UNB-3782

Latest News

By Kelly Baillie on 5th May 2024

Lets Talk About SACT – Let’s Talk About Inequalities & The British Asian Cancer Charity

The next episode of #LetsTalkAboutSact our BOPA Podcast is released on Tuesday Let’s Talk About Inequalities & The British Asian Cancer Charity is out on Tuesday 7th May We are…

Read article
By Joseph Williams on 30th April 2024

Pharmacists’ Essential Guide to Haematology – UCLH Cancer Academy

UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of malignant haematology. SACT-accredited pharmacists who are new to haematology or wish to…

Read article
By BOPA Committee on 30th April 2024

BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a…

Read article
By BOPA Committee on 30th April 2024

Understanding targeted therapies and immunotherapies for cancer (UTIC)- learning course now available

ISOPP (The International Society of Oncology Pharmacy Practitioners) and BOPA (The British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies…

Read article